At EngiLifeSciences, we begin with an assessment process, and a part of the process is helping clients understand their strategic objectives. Following that, we conduct tailored studies at different levels...
Gregory W. Pierce, the CEO of EngiLifeSciences, has been a frontrunner in developing solutions that allow Medical Device, Pharmaceutical and Biotechnology Manufacturers to efficiently bring compliant and high-quality products to...
Increased recalls, pricing pressures and a changing regulatory environment, have many Life Science firms wondering how to prepare for the future. We’ve seen change in the horizon after the FDA...
The next 12 months will likely change the regulatory and compliance landscape for Life Sciences companies. An administration change coupled with a case for quality initiative will drive a new...